• Journal of Acupuncture Research
• /
• 제21권2호
• /
• pp.115-129
• /
• 2004

Objectives : To investigate the analgesic effect and its cholinergic mechanism of electroacupuncture(EA) in the rat model of collagen-induced arthritis(CIA). Methods : Immunization of male Sprague-Dawley rats with bovine typeII (CII) collagen emulsified in Freund's incomplete adjuvant, followed by a booster injection 14 days later, leads to development of arthritis in more than 70% of rats by 21 days postinjection. After three weeks of first immunization, EA stimulation(2 Hz, 0.07 mA, 0.3 ms) was delivered into Jogsamni($ST_{36}$) for 30 minutes. Analgesic effect was evaluated by tail flick latency(TFL). We compared the analgesic effect of EA with TFLs between pretreatment of normal saline and pretreatment of Atropine (1 mg/kg, intraperitoneal) and Neostigmine ($100{\mu}g/kg$, intraperitoneal) in CIA. Results : 1. TFLs were gradually decreased in CIA as increasing severity of arthritis. 2. Jogsamni($ST_{36}$) EA stimulation in CIA increased TFLs and the effect lasted for 60 minutes. 3. Increased TFLs with Jogsamni($ST_{36}$) EA stimulation were inhibited with pretreatment of atropine in CIA 4. Increased TFLs with Jogsamni($ST_{36}$) EA stimulation did not show an obvious synergistic effect with pretreatment of neostigmine in CIA. Conclusions: Jogsamni($ST_{36}$) EA showed analgesic effects in CIA. The analgesic effects of Jogsamni($ST_{36}$) EA were inhibited by atropine pretreatment and combined application of Jogsamni(ST36) EA and neostigmine did not show an synergistic effect. These observations suggest that intrinsic muscarinic cholinergic pathways represent an important modulating system in pain perception of inflammatory pain in CIA It is suggested that, the active mechanism of analgesic effect in EA may involve the release of acetylcholine in the spinal cord.

• Biomolecules & Therapeutics
• /
• 제5권1호
• /
• pp.94-99
• /
• 1997

Capsaicin is known to be an analgesic agent, affecting the synthesis, storage, , transport and release of substance p, the principal neurotransmitter of pain from periphery to the central nervous system(CNS). DA-5018, a newly synthesized capsaicin derivative has shown potent analgesic effect comparable to that of morphine in various rat models of experimentally inducted acute pairs. In this study the mechanism of analgesic actlvity of DA-5018 was examined. First, the electrically-evoked contraction of guinea pig trachea was inhibited by DA-5018 and these inhibition was recovered by incubation with capsafepine(3$\muM$), capsaicin receptor antagonist and this result suggested that DA-5018 has affinity on capsaicin receptor. The correlation between the norciceptive threshold and the release of substance P was evaluated. In vivo perfusion of slices of the rat spinal cord with DA-5018(10, 100$\muM$) produced a significant increase of the release of substance P and this increase was less than that of capsaicin(10$\muM$). The norciceptive threshold of rat treated with DA-5018(1 mg/kg, p.o) in tall pinch test increased from 2.9$\pm$0.3 to 23.5 $\pm$6.61. Tail pinch latency increased to a maximun at 15 min after DA-5018 treatment and then declined to control values by 120 min. The capsaicin-evoked release ot substance P from the spinal cord slices of rat treated with DA-5018 reduced from 2.38$\pm$ 0.79 to 0.69$\pm$ 0.26 pg/mg wet weight. This reduction reached to a minium at 15 min after DA-5018 treatment and then recovered to control value by 120 min. These results mean that analgesic activity of DA-5018 is due to release of substance P The effect of DA-5018 cream on electrically-evoked neurogenic inflammation of rat saphenous nerve was compared with capsaicin (zostrix-HP). DA-5018 showed 34% inhibition of the neurogenic extravasation while capsaicin showed significant 67% inhibition. This result indicates that the potency of DA-5018 in the release of substance P is less than that of capsaicin. These results suggest that the release of substance P is partially involved in the mechanism of analgesic action of DA-50l8.

• 한국임상수의학회지
• /
• 제27권6호
• /
• pp.663-667
• /
• 2010

본 연구는 설치모델 동물에서 봉독의 항통각 효과를 평가하고, 한국산 봉독과 미국산 봉독의 항통각 효과를 비교하는 것이 주된 관심이다. 한국산 봉독은 특별히 고안된 봉독 추출기를 사용하여 일벌 (Apis mellifera L.)에 전기충격을 가하여 생봉독을 수집하였으며, 수집된 생봉독은 봉독 건조기를 이용하여 봉독을 건조하였다. 미국산 봉독은 미국 시그마회사에서 상업적으로 판매되는 건조 봉독을 이용하였다. 한국산 봉독과 미국산 건조봉독을 생리식염수에 희석하여 체중 kg당 6 mg과 0.6 mg, 0.06 mg을 마우스와 랫드에 피하로 투여하여 항진통 효과를 조사하였다. 항통각 효과는 한국산 봉독과 미국산 봉독은 서로 비슷하였으며, 봉독의 용량이 많을수록 항통각 효과가 크게 나타났다. 이상의 결과에서 한국산 건조 봉독은 통증 치료에 사용될 수 있을 것으로 생각된다.

• The Korean Journal of Pain
• /
• 제4권2호
• /
• pp.127-132
• /
• 1991

Recently a non-electronic, disposable and portable infusor(Baxter infusor with patient control module, Baxter health care Co., Deerfield IL 60015 USA: BI $\bar{c}$ PCM) has been developed that will deliver both a continuous drug infusion as well as allow the patient to deliver extra doses of medication on a demand basis under predetermined limitation of analgesics. Patients may also not require as high analgesic dose rate to control pain when the acceptable and tolerable level of pain relief can be maintained by this device. From April l99l, we have used a total l93 units of BI $\bar{c}$ PCM. These units consisting of two components which one made by a balloon reservoir(capacity 65 ml, flow rate 0.5 ml/hr) to store medication and to regulate the pump power(490 torr), and another two PCMs to regulate additional analgesic administration by patients demand at intervals of 1S minutes and 60 minutes. The dose administered to the patient can be varied by changing the concentration of the infusate within the balloon reservoir. These devices were utilized for the pain control of 44 patients. These patients were divided into two groups. Twenty seven cases had cancer pain and 17 cases had non-cancer pain. The Touhy needle(No. l8 G.) tip was inserted into the epidural space and was used to guide the catheter to the spinal nerve level corresponding to the most painful area. The device was connected to the opposite site of the catheter tip and was filled with 60 ml of mixture solution such as 0.5% bupivacaine 15 ml, morphine HCl 10 mg, trazodone 10 ml, Tridol 3 ml and normal saline 31 ml were administed as the initial dose. When the initial dose was less effective, the next dose could be varied by increasing the concentration of bupivacaine, by adding more morphine (5~10 mg), and by reducing the volume of normal saline. Using these modules of drug self administration, we experienced the following: 1) Improvement of patient's self titration of analgesic requirement was provided. 2) The patients anxiety with pain recurrence resulting from delays in administering pain control medication was decreased significantly. 3) The working load accompanying with the single bolus injection as the usual method was reduced remarkably. 4) There was urinary retention in 5 cases and pruritus in 4 eases which developed as side effects but respiratory depression and vomiting was not encountered in a single case.

• 한국식품영양학회지
• /
• 제13권5호
• /
• pp.490-505
• /
• 2000

쑥은 인간의 역사와 함께 하며 많은 품종으로 분화되었고 인간의 식재료도 민간전래약품으로도 이용되어 많은 고전 문헌 속에 쑥의 효능에 대한 기록이 있다. 이러한 쑥의 어떤 성분이 약리적 효능이 있는가 또 어떤 영양성분이 식재료로서 가치가 있는가에 대한 연구가 이루어지고 있다. 오랜동안 쑥은 구황식물로서의 기능이 많았으나 최근에는 그 특성과 향을 이용한 식품개발에도 관심을 갖고 연구하고 있다. 쑥의 일반성분은 녹황색 채소류와 비슷하나 칼슘과 칼륨의 함량이 높고 비타민 A의 함량이 특히 높아 영양보급 효과도 얻을 수 있다. 쑥을 물이나 유기용매에 의하여 추출한 성분은 생리활성을 갖는 경우가 많으며 보편적으로 많이 검출되는 것은 cineol, thujone, borneol, camphor, caryo-phyllene, coumarin, cubebene, pinene, linallol, an-sinthin등이다. 약리적 효과는 고전문헌에 많은 기록이 있으나 대체로 따뜻한 성질을 갖고 있기 때문에 혈행을 왕성하게 하고 간 기능을 도와주며 피부질환에 효과가 있음을 주로 기록하고 있다. 쑥은 잎을 사용하는 경우가 많으나 전초, 꽃, 뿌리, 정유를 이용할 때도 있으며 생쑥 혹은 건조 상태로 이용한다. 민속 약품으로서의 기능도 커서 내복용과 외용으로 쓸 수 있으며 거의 모든 질환에 효과가 있다고 하여 전에는 가정 상비약으로 쓰이기도 했다. 고전문헌이나 전통약품에서 효능이 있다고 알려진 쑥성분에 대한 최근의 연구에서도 고지혈증, 고혈압등 순환기계 질환의 치료 및 예방효과, 간기능 보호, 항돌연변이성 기능, 항염증 및 진통효과, 당뇨병 및 고혈당증의 치료, 생체내 지질의 산화 억제, 항세균 및 항진균효과가 연구보고되어 있으며 유럽에서는 항구충 및 살충효과도 잘 알려져 있다. 유럽에서 행한 쑥의 독성 및 부작용에 대한 연구에서 쑥은 습관성, 향정신적 작용, 피부 염증을 일으킬 수 있다고 하여 장기복용 및 다량 사용을 억제하고 있다. 앞으로의 연구는 식품공업에 다양한 형태로 이용할 수 있는 방법의 개발, 전래된 약효에 대한 과학적인 검증, 타성분과 혼합이용시 생체내 미치는 영향, 여성용품이나 화장수와 같은 생황용품에의 이용방안 등의 연구가 계속되어야 한다. 쑥은 전국에 널리 분포되어 있고 쉽게 채취할 수 있기 때문에 쑥의 이용도를 높이는 것은 자원효율성을 높이고 비용을 절감할 수 있는 좋은 방법이기도 하다.

• 대한정형외과스포츠의학회지
• /
• 제9권1호
• /
• pp.7-15
• /
• 2010

전방 슬관절 동통 증후군은 여러 가지 형태의 다양한 원인으로 서서히 양측 슬개-대퇴 관절 내 또는 주위에 동통을 야기하는 증상이다. 원인으로는 하지의 부적절한 생역학, 전체적인 신전 기전의 병변, 슬개-대퇴 관절 병변, 슬개골 자체의 병변 또는 부정정렬, 단단한 연부조직, 약화된 근육 등이며, 전방 슬관절 동통 증후군을 평가하기 위해서는 슬개골 정열의 측정이 필요하고 현재 이학적 검사 및 방사선 검사 등 다양한 방법이 사용되어 진단 및 치료 정도를 평가하는데 사용되고 있다. 치료는 슬관절 전방 통증의 원인에 따라 결정되며, 주로 수술적 치료보다는 약물 치료나 대퇴사두근 근력 강화 운동, 함스트링 스트레칭운동 등이 보편적으로 사용되고 있다. 경부목 또는 내측 경골 스트레스 증후군은 전내측 경골 원위 2/3 부위에서 발생되는 통증을 의미하며, 반복적이고 조화되지 않는 충격이 하퇴부에 가해지는 스포츠를 하는 체육인에게 흔히 발생된다. 문제의 원인을 정확히 파악하여 진단하는 것이 치료에 매우 중요하며, 따라서 원인, 치료, 재활 및 예방까지 여러 이론이 보고되었다. 치료는 통증이 심할 경우 휴식과 함께 얼음찜질을 실시하며, 진통제를 복용하여 통증을 완화시켜 주는 것이 좋으며, 또한 다리 근육을 강화시켜 줄 수 있는 운동을 하며, 적절한 재활과 예방적 처치가 추후 재발을 방지하는 데 도움이 된다.

• Clinical and Experimental Pediatrics
• /
• 제52권8호
• /
• pp.888-892
• /
• 2009

목 적 : 신생아실에서 만삭아에 준한 경과 관찰 후 퇴원한 후기 조산아들의 재입원과 관련된 위험 요인과 재입원 원인을 알고자 연구를 계획하였다. 방 법 : 2003년 1월부터 2008년 12월까지 일신 기독 병원 신생아실에서 만삭아에 준한 경과 관찰 후 퇴원한 후기 조산아들 중 생후 28일 이내에 재입원하였던 135명의 신생아들의 의무 기록지를 후향적으로 조사하였다. 재입원의 위험 요인을 알고자 대조군과 비교 분석하였다. 결 과 : 재입원과 관련된 위험 요인 연구에서 재태주수, 출생 체중, 성별, 분만 방법, 산모의 나이, 교육 정도, 결혼 여부, 진통과 분만 과정상의 합병증은 관련이 없었고, 모유 수유(71.9% vs 44.4%), 짧은 신생아실 경과 관찰 기간($3.3{\pm}1.6$일 vs $4.1{\pm}2.0$일), 초산모(60.0% vs 45.3%)와 임신 합병증이 있었던 경우(31.9% vs 18.8%) 통계적으로 유의하게 재입원율이 높았다. 재입원 시점은 출생 후 평균 $6.2{\pm}3.6$일로, 출생 5-6일 사이에 재입원하는 경우가 40.7%로 가장 많았다. 재입원 시 83.7%가 황달을 주소로 입원하여 가장 흔한 원인이었고, 자연 분만(43.4% vs 1.8%), 산모의 나이가 적은 경우($29.8{\pm}3.4$세 vs $32.1{\pm}4.2$세), 임신과 관련된 합병증 동반이 적은 경우(28.3% vs 50%)가 황달로 인한 재입원과 관련 있었다. 결론 : 후기 조산아들의 재입원과 관련된 위험 요인은 모유 수유, 짧은 신생아실 경과 관찰 기간, 초산모와 임신 합병증이 있었던 경우였고, 재입원 시점은 평균 $6.2{\pm}3.6$일, 가장 흔한 재입원 원인은 황달이었다.

• The Korean Journal of Pain
• /
• 제18권2호
• /
• pp.133-137
• /
• 2005

Background: Cannabinoids have shown antinociceptive action. The aims of this study were to examine the effect of chronic infusion of a cannabinoids receptors agonist (WIN 55,212-2) for thermal nociception at the spinal level, and to also observe the development of toxicity. Methods: Male Sprague-Dawley rats were implanted with lumbar intrathecal catheters with the nociceptive response (withdrawal response latency) determined by exposing the plantar surface of the hindpaw to radiant heat. Initially, the effect of intrathecal WIN 55,212-2 was evaluated followed by the change in the effect at 1, 2, 3 and 4 weeks after repeated infusion. Finally, the histopathological findings were assessed 1 and 4 weeks following the infusion of WIN 55,212-2. Results: Intrathecal WIN 55,212-2 was found to produce a limited antinociception during the thermal test. %MPE of WIN 55,212-2 at 1, 2, 3, and 4 weeks after infusion was not different from each other. No abnormal pathological findings were observed following a chronic intrathecal infusion of WIN 55,212-2. Conclusions: WIN 55,212-2, a cannabinoids receptors agonist, may be useful in the management of thermal nociception, without changing the effectiveness or causing the toxicity following a chronic infusion at the spinal level.

• The Korean Journal of Pain
• /
• 제18권2호
• /
• pp.165-170
• /
• 2005

Background: It is difficult to treat tourniquet-induced hypertension despite adequate anesthesia, and the mechanism of that is not known. And it may be possible that intraoperative continuous infusion of opioid induces preemptive analgesia postoperatively. We investigated the effect of intraoperative continuous i.v. fentanyl on tourniquet induced cardiovascular changes and postoperative preemptive analgesia in total knee replacements. Methods: Sixty patients were randomly assigned to two groups; In study group ($1.5{\mu}g/kg$ loading and $0.5{\mu}g/kg/hr$ continuous infusion of fentanyl before skin incision and tourniquet inflation) and control group (no treatment). Anesthesia was maintained with enflurane (1-2 MAC) and 50% nitrous oxide in oxygen. Arterial pressure and heart rate were compared between two groups. They received postoperative pain treatment with patient-controlled analgesia (PCA) with fentanyl during the postoperative 48 hours after total knee replacement. Visual analog scale (VAS) scores at either rest or movement were used to assess pain. Total fentanyl dose delivered, number of PCA requests, supplemental analgesics, overall satisfaction score and adverse events were evaluated. Results: There were no significant differences between the two groups on cardiovascular changes by tourniquet induced pain effect. VAS, PCA delivered dose and PCA demands at movement in the 24-48 hour decreased in study group compared with control group (P < 0.05). But there were no significant differences between the two groups on the other time periods except 24-48 hour's patient satisfaction and adverse events. Conclusions: We suggest that intraoperative continuous i.v. fentanyl infusion dose not affect cardiovascular change by tourniquet induced pain. But it may induce preemptive analgesia postoperatively.

• The Korean Journal of Pain
• /
• 제18권2호
• /
• pp.124-132
• /
• 2005

Background: This study was performed to evaluate the dose-related effects of naloxone on morphine analgesia in the rat formalin test, and observe the correlation of pain behavior and spinal c-fos expression induced by a formalin injection. Methods: Fifty rats were divided into five groups; control, morphine (morphine pre-treated, intra-peritoneal injection of 0.1 mg of morphine 5 min prior to formalin injection), and three naloxone groups, which were divided according to the administered dose-ratio of naloxone to morphine 20 : 1 ($5{\mu}g$), 10 : 1 ($10{\mu}g$), and 1 : 1 ($100{\mu}g$) representing the low-, medium-, and high-dose naloxone groups, respectively, were injected intra-peritoneally 16 min after a formalin. A fifty ul of 5% formalin was injected into the right hind paw. All rats were observed for their pain behavior according to the number of flinches during phases 1 (2-3, 5-6 min) and 2 (1 min per every 5 min from 10 to 61 min). The spinal c-fos expression was quantitatively analyzed at 1 and 2 hours after the formalin injection using a real-time PCR. Results: The morphine pre-treated (morphine and three naloxone) groups during phase 1, and the morphine, low- and medium-dose naloxone groups during phase 2, showed significantly less flinches compared to those of the control (P < 0.05). In the three naloxone groups, the numbers of flinches were transiently reduced following the naloxone injection in the low- and medium-dose groups compared to those of the morphine group (P < 0.05). The duration of the reduced flinches was longer in the medium-dose group (P < 0.05). The high-dose group revealed immediate increases in flinches immediately after the naloxone injection compared to those of the morphine, low- and medium-dose groups (P < 0.05 for each). The spinal c-fos expression showed no significant patterns between the experimental groups. Conclusions: Our data suggest that relatively low-dose naloxone (1/20 to 1/10 dose-ratio of morphine) transiently potentiates morphine analgesia; whereas, high-dose (equal dose-ratio of morphine) reverses the analgesia, and the spinal c-fos expression does not always correlate with pain behavior in the rat formalin test.